SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-14-002591
Filing Date
2014-05-15
Accepted
2014-05-15 07:42:17
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tbuff_10q.htm 10-Q 600758
2 CERTIFICATION tbuff_311.htm EX-31.1 14390
3 CERTIFICATION tbuff_312.htm EX-31.2 14595
4 CERTIFICATION tbuff_321.htm EX-32.1 5745
5 CERTIFICATION tbuff_322.htm EX-32.2 6096
  Complete submission text file 0001354488-14-002591.txt   3620935

Data Files

Seq Description Document Type Size
6 tbuff-20140331.xml EX-101.INS 432902
7 tbuff-20140331.xsd EX-101.SCH 42381
8 tbuff-20140331_cal.xml EX-101.CAL 52988
9 tbuff-20140331_def.xml EX-101.DEF 77101
10 tbuff-20140331_lab.xml EX-101.LAB 256625
11 tbuff-20140331_pre.xml EX-101.PRE 185055
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
Tribute Pharmaceuticals Canada Inc. (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31198 | Film No.: 14843854
SIC: 2834 Pharmaceutical Preparations